Nelson, Van Denburg & Campbell Wealth Management Group, LLC Novo Nordisk A S Transaction History

Nelson, Van Denburg & Campbell Wealth Management Group, LLC

$2.63 Billion
Q4 2024

A detailed history of Nelson, Van Denburg & Campbell Wealth Management Group, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Nelson, Van Denburg & Campbell Wealth Management Group, LLC holds 20,597 shares of NVO stock, worth $1.75 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares

20,597

Previous 18,086 13.88%

Holding current value

$1.75 Million

Previous $2.15 Million 17.74%

% of portfolio

0.07%

Previous 0.09%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 17, 2025	BUY	$85.0 - $120.04 $213,435 - $301,420	2,511 Added 13.88%	20,597 $1.77 Million
Q3 2024 Nov 08, 2024	BUY	$119.07 - $145.42 $98,232 - $119,971	825 Added 4.78%	18,086 $2.15 Million
Q2 2024 Aug 13, 2024	SELL	$122.71 - $146.91 $71,785 - $85,942	-585 Reduced 3.28%	17,261 $2.46 Million
Q1 2024 Apr 30, 2024	BUY	$102.11 - $135.92 $315,622 - $420,128	3,091 Added 20.95%	17,846 $2.29 Million
Q4 2023 Jan 30, 2024	SELL	$87.78 - $105.45 $49,771 - $59,790	-567 Reduced 3.7%	14,755 $1.53 Million
Q3 2023 Oct 17, 2023	BUY	$90.94 - $199.54 $696,691 - $1.53 Million	7,661 Added 100.0%	15,322 $1.39 Million
Q2 2023 Jul 19, 2023	SELL	$155.98 - $172.65 $6,863 - $7,596	-44 Reduced 0.57%	7,661 $1.24 Million
Q1 2023 May 10, 2023	BUY	$132.34 - $159.14 $50,686 - $60,950	383 Added 5.23%	7,705 $1.23 Million
Q3 2022 Oct 26, 2022	BUY	$95.28 - $116.93 $8,098 - $9,939	85 Added 1.17%	7,322 $729,000
Q1 2022 May 13, 2022	SELL	$93.1 - $112.54 $43,012 - $51,993	-462 Reduced 6.0%	7,237 $802,000
Q2 2021 Jul 27, 2021	SELL	$67.66 - $84.76 $47,767 - $59,840	-706 Reduced 8.4%	7,699 $644,000
Q4 2020 Feb 09, 2021	BUY	$63.89 - $73.8 $228,917 - $264,425	3,583 Added 74.31%	8,405 $587,000
Q3 2020 Oct 20, 2020	SELL	$63.69 - $70.22 $213,679 - $235,588	-3,355 Reduced 41.03%	4,822 $334,000
Q2 2020 Jul 02, 2020	SELL	$58.54 - $67.94 $341,405 - $396,226	-5,832 Reduced 41.63%	8,177 $535,000
Q1 2020 Apr 01, 2020	SELL	$49.46 - $64.78 $122,561 - $160,524	-2,478 Reduced 15.03%	14,009 $843,000
Q3 2019 Oct 09, 2019	BUY	$47.54 - $53.43 $808 - $908	17 Added 0.1%	16,487 $852,000
Q2 2018 Aug 16, 2018	SELL	$44.29 - $50.42 $4,429 - $5,042	-100 Reduced 0.6%	16,470 $760,000
Q1 2018 May 15, 2018	SELL	$48.49 - $58.14 $154,101 - $184,768	-3,178 Reduced 16.09%	16,570 $816,000
Q4 2017 Feb 08, 2018	BUY	$47.53 - $53.73 $762,333 - $861,775	16,039 Added 432.43%	19,748 $1.06 Million
Q2 2017 Aug 15, 2017	BUY	N/A	3,709	3,709 $159,000

Others Institutions Holding NVO

# of Institutions

1,892

Shares Held

318M

Call Options Held

5.49M

Put Options Held

7.77M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $192B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nelson, Van Denburg & Campbell Wealth Management Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nelson, Van Denburg & Campbell Wealth Management Group, LLC with notifications on news.

Account

Nelson, Van Denburg & Campbell Wealth Management Group, LLC Novo Nordisk A S Transaction History